Company Analysis

Silo Pharma, Inc. (SILO)

Nasdaq: SILO · Pharmaceutical Preparations · Sarasota, FL · filing with the SEC since 2011
Grade4.5
◀ Past 4.8● Present 4.3▶ Future 4.6
2 est.

Who runs Silo Pharma, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Weisblum Eric
Chief Executive Officer. First filing Aug 2014, latest Dec 16, 2025, 22 filings in all.
Officers reporting now
1
of 1 people with a filing in the last fifteen months
Directors reporting now
0
7 people on the record since 2014
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Weisblum EricChief Executive OfficerAug 2014Dec 16, 2025none
Earlier names on the record6, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton SILO · research, not advice